» Articles » PMID: 34040155

Crosstalk Between the Oral Microbiota, Mucosal Immunity, and the Epithelial Barrier Regulates Oral Mucosal Disease Pathogenesis

Overview
Journal Mucosal Immunol
Publisher Elsevier
Date 2021 May 27
PMID 34040155
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Oral mucosal disease (OMD), which is also called soft tissue oral disease, is described as a series of disorders or conditions affecting the mucosa and soft tissue in the oral cavity. Its etiology is unclear, but emerging evidence has implicated the influence of the composition of the oral mucosa and saliva-resident microbiota. In turn, this dysbiosis effects the immune response balance and epithelial barrier function, followed by the occurrence and progression of OMD. In addition, oral microbial dysbiosis is diverse in different types of diseases and different disease progressions, suggesting that key causal pathogens may exist in various oral pathologies. This narrative literature review primarily discusses the most recent findings focusing on how microbial dysbiosis communicates with mucosal adaptive immune cells and the epithelial barrier in the context of five representative OMDs, including oral candidiasis (OC), oral lichen planus (OLP), recurrent aphthous ulcer (RAU), oral leukoplakia (OLK), and oral squamous cell carcinoma (OSCC), to provide new insight into the pathogenetic mechanisms of OMDs.

Citing Articles

The Role of TRPV1/CGRP Pathway Activated by in Pathogenesis of Oral Lichen Planus.

Xu P, Shao R, Zhu P, Fei J, He Y Int J Mol Sci. 2025; 26(2).

PMID: 39859376 PMC: 11766222. DOI: 10.3390/ijms26020662.


Synthetic Vesicle-Based Drug Delivery Systems for Oral Disease Therapy: Current Applications and Future Directions.

Huang P, Li W, Guan J, Jia Y, Wang D, Chen Y J Funct Biomater. 2025; 16(1).

PMID: 39852581 PMC: 11766321. DOI: 10.3390/jfb16010025.


Periodontal bacteria influence systemic diseases through the gut microbiota.

Xi M, Ruan Q, Zhong S, Li J, Qi W, Xie C Front Cell Infect Microbiol. 2024; 14:1478362.

PMID: 39619660 PMC: 11604649. DOI: 10.3389/fcimb.2024.1478362.


Genetically Supported Drug Targets and Dental Traits: A Mendelian Randomization Study.

Liu L, Wang T, Duan C, Mao S, Wu B, Chen Y J Dent Res. 2024; 103(12):1271-1280.

PMID: 39370703 PMC: 11653268. DOI: 10.1177/00220345241272045.


Oral microbiome in human health and diseases.

Tian S, Ding T, Li H mLife. 2024; 3(3):367-383.

PMID: 39359681 PMC: 11442140. DOI: 10.1002/mlf2.12136.


References
1.
Alrashdan M, Cirillo N, McCullough M . Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016; 308(8):539-51. DOI: 10.1007/s00403-016-1667-2. View

2.
Mock D, Scott M, Mock N, Thaler M . The proportion of mitochondrial isoenzyme of aspartate aminotransferase is not elevated in Reye's syndrome. Pediatr Res. 1983; 17(11):884-8. DOI: 10.1203/00006450-198311000-00009. View

3.
Ojeda D, Huber M, Kerr A . Oral Potentially Malignant Disorders and Oral Cavity Cancer. Dermatol Clin. 2020; 38(4):507-521. DOI: 10.1016/j.det.2020.05.011. View

4.
Petersen C, Round J . Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014; 16(7):1024-33. PMC: 4143175. DOI: 10.1111/cmi.12308. View

5.
Levy M, Kolodziejczyk A, Thaiss C, Elinav E . Dysbiosis and the immune system. Nat Rev Immunol. 2017; 17(4):219-232. DOI: 10.1038/nri.2017.7. View